Murgic J - Search Results

1

Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.

Dewaraja YK, Schipper MJ, Shen J, Smith LB, Murgic J, Savas H, Youssef E, Regan D, Wilderman SJ, Roberson PL, Kaminski MS, Avram AM. Dewaraja YK, et al. Among authors: murgic j. J Nucl Med. 2014 Jul;55(7):1047-53. doi: 10.2967/jnumed.113.136044. Epub 2014 May 19. J Nucl Med. 2014. PMID: 24842891 Free PMC article. Clinical Trial.

2

Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.

Soldić Z, Murgić J, Jazvić M, Radić J, Bolanca A, Stancić V, Kusić Z. Soldić Z, et al. Among authors: murgic j. Acta Clin Croat. 2011 Mar;50(1):29-35. Acta Clin Croat. 2011. PMID: 22034781

3

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer.

Murgic J, Stenmark MH, Halverson S, Blas K, Feng FY, Hamstra DA. Murgic J, et al. Radiat Oncol. 2012 Aug 1;7:127. doi: 10.1186/1748-717X-7-127. Radiat Oncol. 2012. PMID: 22852797 Free PMC article.

4

Hypothyroidism as a predictive clinical marker of better treatment response to sunitinib therapy.

Kust D, Prpić M, Murgić J, Jazvić M, Jakšić B, Krilić D, Bolanča A, Kusić Z. Kust D, et al. Among authors: murgic j. Anticancer Res. 2014 Jun;34(6):3177-84. Anticancer Res. 2014. PMID: 24922691

5

DOSIMETRIC VERIFICATION OF INTENSITY MODULATED RADIOTHERAPY (IMRT) TREATMENT PLANS FOR PROSTATE CANCER PATIENTS.

Mrčela I, Gregov M, Matanić A, Budanec M, Murgić J, Jakšić B, Prpić M, Prgomet Sečan A, Frobe A. Mrčela I, et al. Among authors: murgic j. Acta Clin Croat. 2022 Oct;61(Suppl 3):21-27. doi: 10.20471/acc.2022.61.s3.3. Acta Clin Croat. 2022. PMID: 36938551 Free PMC article.

6

MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.

Murgić J, Gregov M, Mrčela I, Budanec M, Krengli M, Fröbe A, Franco P. Murgić J, et al. Acta Clin Croat. 2022 Oct;61(Suppl 3):65-70. doi: 10.20471/acc.2022.61.s3.9. Acta Clin Croat. 2022. PMID: 36938552 Free PMC article. Review.

7

Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature.

Soldić Z, Murgić J, Radić J, Dabelić N, Jazvić M, Brozić JM, Kusić Z. Soldić Z, et al. Among authors: murgic j. Coll Antropol. 2011 Jun;35(2):611-4. Coll Antropol. 2011. PMID: 21755739

8

Time to Nadir PSA: Of Popes and PSA--The Immortality Bias.

Johnson SB, Jackson WC, Murgic J, Feng FY, Hamstra DA. Johnson SB, et al. Among authors: murgic j. Am J Clin Oncol. 2015 Oct;38(5):465-71. doi: 10.1097/COC.0b013e3182a468b2. Am J Clin Oncol. 2015. PMID: 24064749 Clinical Trial.

9

High-dose-rate brachytherapy and concurrent chemoradiotherapy followed by surgery for stage Ib-IIb cervical cancer: single institution experience.

Fröbe A, Jones G, Bokulić T, Mrčela I, Budanec M, Murgić J, Jakšić B, Prpić M, Bolanča A, Kusić Z. Fröbe A, et al. Among authors: murgic j. Anticancer Res. 2014 Jul;34(7):3861-6. Anticancer Res. 2014. PMID: 24982415 Clinical Trial.

10

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.

Murgic J, Jaksic B, Prpic M, Kust D, Bahl A, Budanec M, Prgomet Secan A, Franco P, Kruljac I, Spajic B, Babic N, Kruslin B, Zovak M, Zubizarreta E, Rosenblatt E, Fröbe A. Murgic J, et al. Radiat Oncol. 2021 May 12;16(1):88. doi: 10.1186/s13014-021-01808-3. Radiat Oncol. 2021. PMID: 33980277 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters